The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer

Endocrinol Metab (Seoul). 2024 Apr;39(2):283-284. doi: 10.3803/EnM.2024.201. Epub 2024 Apr 25.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cancer Survivors
  • Humans
  • Hypothyroidism / drug therapy
  • Survivorship
  • Thyroid Neoplasms* / drug therapy
  • Thyroxine* / therapeutic use

Substances

  • Thyroxine